摘要
外来体是由各种类型的细胞分泌的小囊泡,已知其介导细胞之间的信号转导。近年来,用于递送靶向药物,化疗药物和RNA的新型载体正在开发中,这被认为对患者有益。考虑到血液中药物纳米制剂的问题,例如纳米毒性和单核吞噬细胞系统的快速清除,来自患者细胞或体液的外泌体似乎是最佳选择。本综述介绍了当前载入外泌体的药物模式,并讨论了外泌体如何重建靶向治疗。直接加载外泌体或其供体细胞是一种替代方法,包括温育,电穿孔,外来体转染或转染,孵育,亲代细胞的活化。为了解决装载到外泌体中的货物的低效率,通过光学可逆的蛋白质 - 蛋白质相互作用的蛋白质加载可以实现新的外泌体蛋白质载体。此外,通过三种手段实现靶向治疗与外来体,即通过将外泌体中的靶向肽添加到外泌体表面中,通过将外体内的特定基因转移到肿瘤中以建立治疗靶标,最后通过靶向包含肿瘤相关抗原的外来体。然而,外泌体的纯化和大规模生产需要进一步的探索,以及更多的方法应用于靶向治疗。因此,外泌体可以作为药物递送和靶向治疗的有效工具。
关键词: 外来体,药物递送,靶向治疗,癌症,电穿孔,肿瘤相关抗原(TAA)。
Current Cancer Drug Targets
Title:Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy
Volume: 18 Issue: 4
关键词: 外来体,药物递送,靶向治疗,癌症,电穿孔,肿瘤相关抗原(TAA)。
摘要: Exosomes are small vesicles that are secreted by various types of cells, known to mediate signal transduction between cells. During recent years, novel carriers for the delivery of targeted drugs, chemotherapy drugs and RNAs are under development, which is believed to be beneficial for patients. Considering issues of drug nano-formulations in bloodstream, such as nano-toxicity and rapid clearance by mononuclear phagocyte system, exosomes derived from either patient’s cells or bodyfluids, seem to be an optimal option. This review presents the current patterns of drug-loaded into exosomes and discusses how exosomes were reconstructed for targeted therapy. Loading either exosomes directly or their donor cells is an alternative, including incubation, electroporation, transfection of exosomes or transfection, incubation, activation of the parent cells. To solve the low efficiency of cargo loading into exosomes, protein loading via optically reversible protein-protein interaction can realize a novel exosomal protein carrier. In addition, targeted therapeutics with exosomes is achieved by three means, via adding targeting peptides into the surface of exosomes, by transferring specific genes within exosomes into tumors to establish a therapeutic target and, lastly, by targeting at exosomes containing tumor associated antigens. Nevertheless, purification and mass production of exosomes need further exploration, as well as more approaches were applied to targeted therapy. Therefore, exosomes could serve as an effective tool for drug delivery and targeted therapy.
Export Options
About this article
Cite this article as:
Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy, Current Cancer Drug Targets 2018; 18 (4) . https://dx.doi.org/10.2174/1568009617666170710120311
DOI https://dx.doi.org/10.2174/1568009617666170710120311 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evolution and Pathogenesis of Oncoviruses Associated with Head and Neck Cancer: History and Current Concepts
Recent Patents on Biomarkers Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review
Current Drug Metabolism Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety Estrogen-Induced Genetic Alterations and Their Role in Carcinogenicity
Current Genomics Novel Approaches in the Synthesis of Batracylin and Its Analogs: Rebirth of an Old Player?
Current Medicinal Chemistry Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Molecular Testing and Personalized Treatment of Lung Cancer
Current Molecular Pharmacology EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy Acknowledgements to Reviewers
Anti-Cancer Agents in Medicinal Chemistry Early Detection of Central Nervous System Relapse of Pediatric Leukemia with Measurement of Optic Nerve Sheath Diameter on MRI
Current Medical Imaging Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Anti-Cancer Agents in Medicinal Chemistry Molecular Treatment of Different Breast Cancers
Anti-Cancer Agents in Medicinal Chemistry Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Review of Bioinformatics and Theoretical Studies of Acetylcholinesterase Inhibitors
Current Bioinformatics Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets The Prevention and Inhibition Effect of Anthocyanins on Colorectal Cancer
Current Pharmaceutical Design Dual Nuclear/Fluorescence Imaging Potantial of Zinc(II) Phthalocyanine in MIA PaCa-2 Cell Line
Current Radiopharmaceuticals <i>In vitro</i> and <i>in vivo</i> Evaluation of 17-phenylpropylamine/phenoxyethylamine- 17-demethoxygeldanamycins as Potent Hsp90 Inhibitors
Medicinal Chemistry Hepatic Delivery of RNA Interference Activators for Therapeutic Application
Current Gene Therapy Application of Nanomedicine in Cardiovascular Diseases and Stroke
Current Pharmaceutical Design